BCM
ANGO icon

Bayesian Capital Management’s AngioDynamics ANGO Stock Holding History

Bayesian Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,131
Closed -$106K – 715
2024
Q1 		$106K Buy
+18,131
New +$108K 0.01% 707
2018
Q4 		– Sell
-13,455
Closed -$293K – 603
2018
Q3 		$293K Buy
+13,455
New +$299K 0.05% 465

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bayesian Capital Management's ANGO Position: Q2 2024 in Review

Bayesian Capital Management sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 18,131 shares — an estimated $106K sold.

Bayesian Capital Management first reported a position in ANGO in Q3 2018 and held it in 2 quarters. The position peaked at $293K in Q3 2018. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Bayesian Capital Management reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 18,131 AngioDynamics shares in Q2 2024, an estimated $106K.
  • Bayesian Capital Management first reported a position in AngioDynamics in Q3 2018 and held it in 2 quarters.
  • Bayesian Capital Management's AngioDynamics position peaked at $293K in Q3 2018.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.